Virtu KCG Holdings’s Biogen BIIB Stock Holding History

Virtu KCG Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-34,500	Closed	-$10.6M	–	2818
2015 Q4	$10.6M	Buy	34,500 +4,000	+13%	+$1.15M	0.18%	56
2015 Q3	$8.9M	Buy	30,500 +13,800	+83%	+$4.56M	0.15%	69
2015 Q2	$6.75M	Buy	16,700 +7,900	+90%	+$3.17M	0.12%	80
2015 Q1	$3.72M	Sell	8,800 -4,800	-35%	-$1.89M	0.08%	175
2014 Q4	$4.62M	Sell	13,600 -600	-4%	-$194K	0.08%	165
2014 Q3	$4.7M	Sell	14,200 -10,700	-43%	-$3.53M	0.09%	155
2014 Q2	$7.85M	Sell	24,900 -4,400	-15%	-$1.32M	0.12%	98
2014 Q1	$8.96M	Buy	29,300 +3,900	+15%	+$1.24M	0.11%	132
2013 Q4	$7.1M	Sell	25,400 -7,200	-22%	-$1.86M	0.08%	149
2013 Q3	$7.85M	Buy	+32,600	New	+$7.3M	0.1%	128

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's BIIB Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Biogen (BIIB) stake by 48% in Q2 2017, selling an estimated $1.69M and leaving 7,022 shares worth $1.91M. The position accounts for 0.05% of the portfolio, ranked #268.

Virtu KCG Holdings first reported a position in BIIB in Q3 2013 and has held it in 13 quarters since. The position peaked at $14.2M in Q1 2015. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Virtu KCG Holdings held 7,022 shares of Biogen worth $1.91M as of Q2 2017.
Virtu KCG Holdings sold 6,404 Biogen shares in Q2 2017, an estimated $1.69M.
Biogen made up 0.05% of Virtu KCG Holdings's portfolio in Q2 2017, its #268 holding.
Virtu KCG Holdings first reported a position in Biogen in Q3 2013 and has held it in 13 quarters since.
Virtu KCG Holdings's Biogen position peaked at $14.2M in Q1 2015.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.